Frailty Assessment and Phenotypes

Frailty is a state of heightened vulnerability to adverse outcomes that arises from cumulative decline across multiple physiological systems, leaving an older person less able to withstand stressors. Its assessment is dominated by two influential operationalisations — the physical frailty phenotype and the deficit-accumulation frailty index — which conceptualise and measure frailty in distinct ways.

Definition

Frailty is a clinical state of increased vulnerability to stressors resulting from age-associated decline in reserve and function across multiple physiological systems; it is operationalised chiefly as a physical phenotype defined by specific signs or as an index reflecting the accumulation of health deficits.

Scope

This entry covers the concept of frailty, the two principal measurement models (the Fried phenotype and the Rockwood-Mitnitski deficit-accumulation index), the clinical frailty scale, and the debates between phenotype and index approaches. It treats frailty assessment as a methodological topic, not as treatment guidance.

Core questions

• How is frailty distinguished from normal ageing, disability, and multimorbidity?
• How do the physical phenotype and the deficit-accumulation index differ in defining and measuring frailty?
• What are the implications of treating frailty as a discrete syndrome versus a continuous accumulation of deficits?

Key concepts

• Frailty phenotype (Fried criteria)
• Deficit-accumulation frailty index
• Clinical Frailty Scale
• Physiological reserve and vulnerability
• Distinction from disability and multimorbidity
• Continuous versus categorical frailty

Key theories

Physical frailty phenotype

Fried and colleagues define frailty as a clinical syndrome present when three or more of five criteria occur — unintentional weight loss, self-reported exhaustion, weakness (grip strength), slow walking speed, and low physical activity — framing frailty as a distinct biological phenotype that predicts adverse outcomes.

Deficit-accumulation frailty index

Mitnitski, Rockwood, and colleagues model frailty as the proportion of accumulated health deficits an individual has out of a counted total, treating frailty as a continuous quantity reflecting overall biological ageing rather than a fixed set of criteria.

Mechanisms

Frailty is conceived as the consequence of decline across multiple physiological systems that reduces reserve and the capacity to recover from stressors. The phenotype model captures this through observable manifestations such as weakness, slowness, exhaustion, weight loss, and low activity, positing an underlying cycle of decline. The deficit-accumulation model instead counts a wide range of symptoms, signs, diseases, and disabilities and expresses frailty as the fraction present, so that more accumulated deficits indicate greater biological ageing and vulnerability. The Clinical Frailty Scale offers a judgement-based ordinal summary aligned with the deficit-accumulation tradition, giving clinicians a brief global rating.

Clinical relevance

Frailty is a central organising concept in geriatric medicine for describing vulnerability and stratifying risk among older adults. This entry explains how frailty is conceptualised and measured and summarises its evidence base; it is reference-educational and is not a basis for individual diagnostic, prognostic, or treatment decisions.

Epidemiology

Frailty becomes more common with advancing age and is associated with adverse outcomes including falls, hospitalisation, and loss of independence, as summarised in reviews such as Clegg and colleagues (2013). Measured prevalence varies with the instrument and population, partly reflecting differences between phenotype and deficit-accumulation definitions.

History

Frailty moved from an informal clinical notion to a measurable construct around the turn of the twenty-first century. In 2001 Fried and colleagues proposed an operational physical phenotype using Cardiovascular Health Study data, while Mitnitski, Rockwood, and colleagues introduced the deficit-accumulation index the same year. The Clinical Frailty Scale followed in 2005, a standardised procedure for building frailty indices was published by Searle and colleagues in 2008, and influential syntheses by Clegg and colleagues (2013) and Dent and colleagues (2019) consolidated the field.

Debates

Phenotype versus deficit-accumulation index

The two dominant models conceptualise frailty differently — as a discrete syndrome defined by specific physical criteria versus a continuous count of accumulated deficits — and they can classify individuals differently, leaving the choice of model and its consequences an active methodological debate.

Key figures

• Linda P. Fried
• Kenneth Rockwood
• Arnold Mitnitski
• Andrew Clegg
• Elsa Dent

Seminal works

• fried-2001
• mitnitski-2001
• rockwood-2005

Frequently asked questions

What is the difference between the frailty phenotype and the frailty index?

The frailty phenotype (Fried criteria) defines frailty as a syndrome present when several specific physical signs — such as weakness, slowness, and weight loss — co-occur, whereas the frailty index (Rockwood-Mitnitski) measures frailty as the proportion of accumulated health deficits, treating it as a continuous quantity.

Is frailty the same as having many diseases or being disabled?

No. Frailty refers to reduced physiological reserve and heightened vulnerability to stressors; although it overlaps with multimorbidity and disability, it is conceptually distinct, and a person can be frail without being disabled or have multiple diseases without being frail.